Myofibroblasts are increased in the lung parenchyma in asthma

Increased airway smooth muscle is observed in large and small airways in asthma. Semi-quantitative estimates suggest that cells containing alpha smooth muscle actin (α-SMA) are also increased in the lung parenchyma. This study quantified and characterized α-SMA positive cells (α-SMA+) in the lung pa...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 12; no. 8; p. e0182378
Main Authors Boser, Stacey R., Mauad, Thais, Araújo-Paulino, Bianca Bergamo de, Mitchell, Ian, Shrestha, Grishma, Chiu, Andrea, Butt, John, Kelly, Margaret M., Caldini, Elia, James, Alan, Green, Francis H. Y.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 07.08.2017
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Increased airway smooth muscle is observed in large and small airways in asthma. Semi-quantitative estimates suggest that cells containing alpha smooth muscle actin (α-SMA) are also increased in the lung parenchyma. This study quantified and characterized α-SMA positive cells (α-SMA+) in the lung parenchyma of non-asthmatic and asthmatic individuals. Post-mortem sections of peripheral lung from cases of fatal asthma (FA), persons with asthma dying of non-respiratory causes (NFA) and non-asthma control subjects (NAC) were stained for α-SMA, quantified using point-counting and normalised to alveolar basement membrane length and interstitial area. α-SMA+ fractional area was increased in alveolar parenchyma in both FA (14.7 ± 2.8% of tissue area) and NFA (13.0 ± 1.2%), compared with NAC (7.4 ± 2.4%), p < 0.05 The difference was greater in upper lobes compared with lower lobes (p < 0.01) in both asthma groups. Similar changes were observed in alveolar ducts and alveolar walls. The electron microscopic features of the α-SMA+ cells were characteristic of myofibroblasts. We conclude that in asthma there is a marked increase in α-SMA+ myofibroblasts in the lung parenchyma. The physiologic consequences of this increase are unknown.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors also contributed equally to this work.
Competing Interests: JB is the owner and president of Pathfinder Forum Consulting Inc. The company owns shares in various equities; none of these are related to research in the field of pulmonary morphology/histopathology including asthma. Pathfinder Forum Consulting Inc. provides consulting services only and exclusively in the area of litigation support to legal council. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0182378